To address these early and late aspects , 2291 patients presenting with acute or stable coronary disease needing stents 3.0 mm in diameter between April 2010 and May 2012 were randomly assigned to biolimus-A9-eluting BP-DES , second-generation everolimus-eluting DP-DES , or thin-strut silicon-carbide-coated BMS in 8 European centers .